PLATO

AVROBIO, Inc.

Application Filed: 2019-01-25
Trademark Application Details
Trademark Logo PLATO

Mark For: PLATO® trademark registration is intended to cover the categories of pharmaceuticals for treatment of rare and other diseases, namely, autoimmune diseases, diseases of the central nervous system, and oncological diseases. [all]

Status

2021-07-25 UTC
LIVE APPLICATION Under Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and that this application has been assigned to an examiner.


Research OneLook Acronym Finder
Serial Number88276835
Registration Number1481459
Mark Literal ElementsPLATO
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTRADEMARK
RegisterPRINCIPAL
Current LocationDIVISIONAL UNIT 2020-04-21
Basis1(b)
Class StatusACTIVE
Primary US Classes
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseNo
Current UseNo
Intent To UseYes
Filed ITUYes
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameMichael J. Belliveau
Attorney Docket Number51182-T02001
Law Office AssignedM50
Employee NameNEVILLE, JAMES B

Timeline

2019-01-25Application Filed
2019-04-08Location: TMO LAW OFFICE 114
2019-04-08Status: Live/Pending
2019-04-08Transaction Date
2019-08-13Published
2019-08-13Published for Opposition
2020-04-21Location: DIVISIONAL UNIT
2021-04-06Status: A third request for extension of time to file a Statement of Use has been granted.

Trademark Parties (Applicants & Owners)

Party: AVROBIO, Inc.
AddressBuilding 300, Suite 201 One Kendall Square Cambridge, MASSACHUSETTS UNITED STATES 02139
Legal Entity TypeCorporation
Legal Entity StateDELAWARE

Attorney of Record

MICHAEL J. BELLIVEAU
CLARK+ELBING LLP
101 FEDERAL STREET, 15TH FLOOR
BOSTON, MA 02110

Good, Services, and Codes


IC 005. US 006 018 044 046 051 052. G & S: Pharmaceuticals for treatment of rare and other diseases, namely, autoimmune diseases, diseases of the central nervous system, and oncological diseases

International Codes:5
U.S. Codes:006,018,044,046,051,052
International Codes:9
U.S. Codes:021,023,026,036,038
International Codes:42
U.S. Codes:100,101
Type CodeType
GS0091Gene therapy development platform for treatments for rare and other diseases; pharmaceuticals for treatment of rare and other diseases; advertisement materials for pharmaceuticals for treatment of rare and other diseases

Trademark Filing History

DescriptionDateProceeding Number
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2021-04-08
TEAS EXTENSION RECEIVED2021-04-06
EXTENSION 3 GRANTED2021-04-0698765
EXTENSION 3 FILED2021-04-0698765
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2020-10-08
TEAS EXTENSION RECEIVED2020-10-06
EXTENSION 2 GRANTED2020-10-0698765
EXTENSION 2 FILED2020-10-0698765
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2020-04-22
CORRECTED NOA E-MAILED2020-04-22
EXTENSION 1 GRANTED2020-04-2166154
DIVISIONAL PROCESSING COMPLETE2020-04-21
CASE ASSIGNED TO INTENT TO USE PARALEGAL2020-04-2166154
TEAS REQUEST TO DIVIDE RECEIVED2020-03-31
TEAS EXTENSION RECEIVED2020-03-31
EXTENSION 1 FILED2020-03-3166154
DIVISIONAL REQUEST RECEIVED2020-03-31
NOA E-MAILED - SOU REQUIRED FROM APPLICANT2019-10-08
PUBLISHED FOR OPPOSITION2019-08-13
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2019-08-13
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2019-07-24
ASSIGNED TO LIE2019-07-1168171
APPROVED FOR PUB - PRINCIPAL REGISTER2019-06-27
TEAS/EMAIL CORRESPONDENCE ENTERED2019-06-2188889
TEAS RESPONSE TO OFFICE ACTION RECEIVED2019-06-20
CORRESPONDENCE RECEIVED IN LAW OFFICE2019-06-2088889
NOTIFICATION OF NON-FINAL ACTION E-MAILED2019-04-126325
NON-FINAL ACTION WRITTEN2019-04-1276737
NON-FINAL ACTION E-MAILED2019-04-126325
ASSIGNED TO EXAMINER2019-04-0876737
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2019-02-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed